 | Up a level |
Bill, Ruben; Faquin, William C; Pai, Sara I (2023). Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations. Head and neck pathology, 17(4), pp. 969-975. Springer 10.1007/s12105-023-01590-6
Bill, Ruben; Wirapati, Pratyaksha; Messemaker, Marius; Roh, Whijae; Zitti, Beatrice; Duval, Florent; Kiss, Máté; Park, Jong Chul; Saal, Talia M; Hoelzl, Jan; Tarussio, David; Benedetti, Fabrizio; Tissot, Stéphanie; Kandalaft, Lana; Varrone, Marco; Ciriello, Giovanni; McKee, Thomas A; Monnier, Yan; Mermod, Maxime; Blaum, Emily M; ... (2023). CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science, 381(6657), pp. 515-524. American Association for the Advancement of Science 10.1126/science.ade2292
Fernandez-Rodriguez, Laura; Cianciaruso, Chiara; Bill, Ruben; Trefny, Marcel P; Klar, Richard; Kirchhammer, Nicole; Buchi, Mélanie; Festag, Julia; Michel, Sven; Kohler, Rainer H; Jones, Elham; Maaske, Andre; Kashyap, Abhishek S; Jaschinski, Frank; Dixon, Karen O; Pittet, Mikael J; Zippelius, Alfred (2023). Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. Journal for immunotherapy of cancer, 11(5) BioMed Central 10.1136/jitc-2023-006714
Gungabeesoon, Jeremy; Gort-Freitas, Nicolas A; Kiss, Máté; Bolli, Evangelia; Messemaker, Marius; Siwicki, Marie; Hicham, Mehdi; Bill, Ruben; Koch, Peter; Cianciaruso, Chiara; Duval, Florent; Pfirschke, Christina; Mazzola, Michael; Peters, Solange; Homicsko, Krisztian; Garris, Christopher; Weissleder, Ralph; Klein, Allon M; Pittet, Mikael J (2023). A neutrophil response linked to tumor control in immunotherapy. Cell, 186(7), pp. 1448-1464. Cell Press 10.1016/j.cell.2023.02.032
Wang, Chen; Barnoud, Coline; Cenerenti, Mara; Sun, Mengzhu; Caffa, Irene; Kizil, Burak; Bill, Ruben; Liu, Yuanlong; Pick, Robert; Garnier, Laure; Gkountidi, Olga A; Ince, Louise M; Holtkamp, Stephan; Fournier, Nadine; Michielin, Olivier; Speiser, Daniel E; Hugues, Stéphanie; Nencioni, Alessio; Pittet, Mikaël J; Jandus, Camilla; ... (2023). Dendritic cells direct circadian anti-tumor immune responses. Nature, 614(7946), pp. 136-143. Springer Nature 10.1038/s41586-022-05605-0
Bill, Ruben; Deschler, Daniel G; Pittet, Mikael J; Pai, Sara I; Sadow, Peter M; Park, Jong Chul (2022). Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands. Cancer reports, 5(3), e1491. Wiley 10.1002/cnr2.1491
Siwicki, Marie; Gort-Freitas, Nicolas A; Messemaker, Marius; Bill, Ruben; Gungabeesoon, Jeremy; Engblom, Camilla; Zilionis, Rapolas; Garris, Christopher; Gerhard, Genevieve M; Kohl, Anna; Lin, Yunkang; Zou, Angela E; Cianciaruso, Chiara; Bolli, Evangelia; Pfirschke, Christina; Lin, Yi-Jang; Piot, Cecile; Mindur, John E; Talele, Nilesh; Kohler, Rainer H; ... (2021). Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy. Science immunology, 6(61) American Association for the Advancement of Science 10.1126/sciimmunol.abi7083
Kashyap, Abhishek S; Schmittnaegel, Martina; Rigamonti, Nicolò; Pais-Ferreira, Daniela; Mueller, Philipp; Buchi, Melanie; Ooi, Chia-Huey; Kreuzaler, Matthias; Hirschmann, Petra; Guichard, Alan; Rieder, Natascha; Bill, Ruben; Herting, Frank; Kienast, Yvonne; Dirnhofer, Stefan; Klein, Christian; Hoves, Sabine; Ries, Carola H; Corse, Emily; De Palma, Michele; ... (2020). Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 117(1), pp. 541-551. National Academy of Sciences NAS 10.1073/pnas.1902145116
Bill, Ruben; Schardt, Julian (2019). [Immunotherapies - Overview, mode of action and clinical implications]. Therapeutische Umschau, 76(4), pp. 187-194. Hogrefe 10.1024/0040-5930/a001083
Lüönd, Fabiana; Bill, Ruben; Vettiger, Andrea; Oller, Heide; Pelczar, Pawel; Christofori, Gerhard (2019). A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse Models. Journal of mammary gland biology and neoplasia, 24(1), pp. 39-45. Springer 10.1007/s10911-018-9412-4
Tiede, Stefanie; Meyer-Schaller, Nathalie; Kalathur, Ravi Kiran Reddy; Ivanek, Robert; Fagiani, Ernesta; Schmassmann, Philip; Stillhard, Patrick; Häfliger, Simon; Kraut, Norbert; Schweifer, Norbert; Waizenegger, Irene C; Bill, Ruben; Christofori, Gerhard (2018). The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer. Oncogenesis, 7(9), p. 73. Springer Nature 10.1038/s41389-018-0083-1
Bill, Ruben; Montani, Matteo; Blum, Benedikt; Dufour, Jean-François; Escher, Robert; Bühlmann, Michael (2018). Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver. Hepatology, 68(1), pp. 384-386. Wiley Interscience 10.1002/hep.29853
Wiedmer, Tabea; Blank, Annika; Pantasis, Sophia; Normand, Lea Elena Haaning; Bill, Ruben; Krebs, Philippe; Tschan, Mario; Marinoni, Ilaria; Perren, Aurel (2017). Autophagy inhibition improves sunitinib efficacy in pancreatic neuroendocrine tumors via a lysosome-dependent mechanism. Molecular cancer therapeutics, 16(11), pp. 2502-2515. American Association for Cancer Research AACR 10.1158/1535-7163.MCT-17-0136
Bill, Ruben; Döring, Axinia; Deutsch, Urban; Engelhardt, Britta (2011). PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice. Journal of neuroimmunology, 232(1-2), pp. 207-8. Amsterdam: Elsevier 10.1016/j.jneuroim.2010.10.008
